Scandinavian Real Heart AB (Publ)
Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis to fix the sternum after open-chest surgery. The company was founded in 1999 and is bas… Read more
Scandinavian Real Heart AB (Publ) (7820) - Total Liabilities
Latest total liabilities as of June 2025: €13.59 Million EUR
Based on the latest financial reports, Scandinavian Real Heart AB (Publ) (7820) has total liabilities worth €13.59 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Scandinavian Real Heart AB (Publ) - Total Liabilities Trend (2021–2024)
This chart illustrates how Scandinavian Real Heart AB (Publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Scandinavian Real Heart AB (Publ) Competitors by Total Liabilities
The table below lists competitors of Scandinavian Real Heart AB (Publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Castle Peak Holdings Public Company Limited
BK:CPH
|
Thailand | ฿568.02 Million |
|
Plaza Centers NV
WAR:PLZ
|
Poland | zł162.91 Million |
|
Vaishali Pharma Limited
NSE:VAISHALI
|
India | ₹545.40 Million |
|
TVA Group Inc
PINK:TVAGF
|
USA | $220.69 Million |
|
Salarius Pharmaceuticals Inc
NASDAQ:SLRX
|
USA | $1.85 Million |
|
Genesis Fertility Center Public Company Limited
BK:GFC
|
Thailand | ฿90.39 Million |
|
Interra Copper Corp
OTCQB:IMIMF
|
USA | $244.65K |
Liability Composition Analysis (2021–2024)
This chart breaks down Scandinavian Real Heart AB (Publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Scandinavian Real Heart AB (Publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Scandinavian Real Heart AB (Publ) (2021–2024)
The table below shows the annual total liabilities of Scandinavian Real Heart AB (Publ) from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €15.94 Million | -22.62% |
| 2023-12-31 | €20.60 Million | -7.08% |
| 2022-12-31 | €22.17 Million | +239.78% |
| 2021-12-31 | €6.53 Million | -- |